๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Testicular Function in Poor-Risk Nonseminomatous Germ Cell Tumors Treated With Methotrexate, Paclitaxel, Ifosfamide, and Cisplatin Combination Chemotherapy

โœ Scribed by Pectasides, D.; Pectasides, E.; Papaxoinis, G.; Skondra, M.; Gerostathou, M.; Karageorgopoulou, S.; Kamposioras, C.; Tountas, N.; Koumarianou, A.; Psyrri, A.; Macheras, A.; Economopoulos, T.

Book ID
119924721
Publisher
American Society of Andrology
Year
2009
Tongue
English
Weight
278 KB
Volume
30
Category
Article
ISSN
1939-4640

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cisplatin-based (PVB+M) chemotherapy in
Cisplatin-based (PVB+M) chemotherapy in good-risk and poor-risk nonseminomatous germ cell tumors
โœ Dr. Tapan Saikia; Upendra Hegde; Suresh Advani; Gopal Ramakrishnan; Jagdeesh Kul ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 313 KB

Twenty-seven patients with metastatic nonseminomatous germ cell tumors were treated with Cisplatin, vinblastine, bleomycin, and low-dose methotrexate (PVB + M) combinations. Patients were divided into good-risk and poor-risk groups. All seven patients (100%) with good-risk factors achieved complete

VAB-5 combination chemotherapy in progno
VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors
โœ Davor Vugrin; Willet F. Whitmore; Robert B. Golbey ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 429 KB ๐Ÿ‘ 2 views

Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab